X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Thoracic Cancer

期刊標題檢索 THORAC CANCER 最新評論: I would like to ask if the absence of "under review" in the initial re... (2024-11-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Thoracic Cancer]您好,您是該頁面的第 65782 位訪客。

期刊簡介
期刊名稱Thoracic Cancer Thoracic Cancer
LetPub Score
6.2
50 ratings
Rate

Reputation
7.0

Influence
4.9

Speed
9.4

期刊簡稱THORAC CANCER
ISSN1759-7706
E-ISSN1759-7714
h-index20
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.200.7780.785
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pulmonary and Respiratory Medicine
Q254 / 155
Category: Medicine
Subcategory: Oncology
Q2160 / 404

自引率 (2023-2024)4.30%自引率趨勢
掲載範囲
Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.

The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1759-7714
在線稿件提交https://mc.manuscriptcentral.com/tca
開放訪問Yes
出版商Blackwell Publishing Asia Pty Ltd
主題領域ONCOLOGY
出版國/地區PEOPLES R CHINA
發行頻率
創刊年2010
每年文章數374每年文章數趨勢
黃金OA百分比68.37%
OA Related Info
APC: Yes( USD2750; GBP1850; EUR2500; )
APC waiver:Check Notes
Other charges: No
Keywords: treatment and research、asia-pacific、thoracic cancer、prevention
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3201/322
RESPIRATORY SYSTEMSCIEQ250/100
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1759-7706%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【Thoracic Cancer】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Lancet Respiratory MedicineH-index: 79

    CiteScore: 87.10
    Journal of Breath ResearchH-index: 45

    CiteScore: 7.60
    npj Primary Care Respiratory MedicineH-index: 16

    CiteScore: 5.50
    Annals of Thoracic MedicineH-index: 29

    CiteScore: 4.10
    Primary Care Respiratory JournalH-index: 44

    CiteScore: 0.00
    學科內最受檢索的期刊 頁面查看次數
    Lancet Respiratory Medicine30643
    Journal of Breath Research20568
    Annals of Thoracic Medicine13645
    npj Primary Care Respiratory Medicine12743
    Primary Care Respiratory Journal8767
  •  

    Thoracic Cancer Thoracic Cancer
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [Thoracic Cancer] 的評論撰寫評論
作者: soft


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-06 18:35:50 評論於
I would like to ask if the absence of "under review" in the initial review status and directly showing "Awaiting EIC Assignment" means that my submission will be rejected?
(0) 讚! | soft

作者: 金刚统维


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-26 17:12:33 評論於
Submission success rate: 5.0. Experience sharing: Be cautious when submitting to rubbish magazines, you need connections.
(0) 讚! | 金刚统维

作者: mint


領域: 医学
審稿時間: 12.0 month(s)
結果: 拒稿


撰寫評論

2024-06-04 23:11:26 評論於
Rejecting in one week is actually quite fast
(0) 讚! | mint

作者: 耍威风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-27 10:04:19 評論於
What kind of validation are you doing? I am also doing bioinformatics and cell experiments, planning to give it a try
(0) 讚! | 耍威风

作者: Ursula Malory


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-05 08:20:09 評論於
Last update; Major overhaul in 2 weeks, reception 3 days after rework! Hope everything goes smoothly for everyone!
(0) 讚! | Ursula Malory

作者: Ursula Malory


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-22 09:31:56 評論於
Update status; 35 days for first review response, major revisions. May need to rewrite the introduction and discussion
(0) 讚! | Ursula Malory

作者: Ursula Malory


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-17 16:10:20 評論於
Updating status; it's been a month and still no news, it seems the online claim of 18 days for the first review is not reliable
(0) 讚! | Ursula Malory

作者: Ursula Malory


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-28 22:55:12 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Focused research areas: mechanism; lung cancer; tumor
Experience sharing: Submitted on the second day and is under review, but there has been no change in status since then. Currently no news. Original data needs to be submitted. After looking at the recently published articles, the quality is all good, with acceptance times around 1-2 months. Hopefully, my submission will also be successful!
(0) 讚! | Ursula Malory

作者: 墟散凌山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-22 23:07:26 評論於
Review Speed: 1.0 
Main Research Focus: Lung Cancer 
Sharing Experience: Case Study 
Rejected in 2 days, feeling discouraged
(0) 讚! | 墟散凌山

作者: 北陆一凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-14 21:15:01 評論於
I was just rejected ?
(0) 讚! | 北陆一凡

作者: 北陆一凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-13 14:21:51 評論於
How are you doing? I am also facing the same problem now
(0) 讚! | 北陆一凡

作者: 琴心少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-27 11:25:57 評論於
Are you still conducting meta-analyses recently?
(0) 讚! | 琴心少爷

作者: 光明熙星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-03 23:50:00 評論於
Research focus: Basic experimental experience sharing
I want to ask if anyone has recently submitted to this journal. How fast is the review process? I have submitted for a week and haven't been assigned an editor yet. Is this normal?
(0) 讚! | 光明熙星

作者: Adolph Wood


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-30 11:51:18 評論於
Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR
(0) 讚! | Adolph Wood

作者: 月河莉霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-05 22:09:38 評論於
Review Speed: 1.0
Experience Sharing: I submitted a bioinformatics paper for verification, and it got rejected the next day. I feel that this journal may not be easy to publish in, but the quality is good. After looking at the bioinformatics papers published by this journal in the past year, most of them seem to involve cell experiments
(0) 讚! | 月河莉霞

作者: 东海春兴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-24 21:03:21 評論於
Research focus: Lung cancer; Tumor experience sharing: Meta-analysis submission, rejected in 3 days
(0) 讚! | 东海春兴

作者: 一条小德才


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-30 09:03:28 評論於
 (0) 讚! | 一条小德才  

作者: 华清智晖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-24 18:58:03 評論於
Is this issue resolved?
(0) 讚! | 华清智晖

作者: 华清智晖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-24 17:36:14 評論於
How to solve this problem?
(0) 讚! | 华清智晖

作者: 华清智晖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-07 17:42:59 評論於
How much is the layout fee?
(0) 讚! | 华清智晖

作者: 华清智晖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-07 09:39:52 評論於
Is the layout expensive?
(0) 讚! | 华清智晖

作者: Abner Maria


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-25 09:38:00 評論於
Correct
(0) 讚! | Abner Maria

作者: 墟散熙研


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-05 09:39:26 評論於
Can only OA be selected for this magazine?
(0) 讚! | 墟散熙研

作者: 八荒柔静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-01 13:06:17 評論於
Do you need to pay a reviewing fee?
(0) 讚! | 八荒柔静

作者: 终幕香巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-29 23:37:13 評論於
When submitting a manuscript, how can I find out who the reviewers are, and how can I add reviewers?
(0) 讚! | 终幕香巧

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [Thoracic Cancer] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*